Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy

被引:146
作者
Sabol, K
Patterson, JE
Lewis, JS
Owens, A
Cadena, J
Jorgensen, JH
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, S Texas Vet Affairs Healthcare Syst, San Antonio, TX 78229 USA
[3] Univ Texas, Hlth Sci Ctr, Univ Hlth Syst, Serv Pharm, San Antonio, TX 78229 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA
[5] Univ Texas, Hlth Sci Ctr, Clin Pharm, San Antonio, TX 78229 USA
[6] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA
[7] Univ Texas, Hlth Sci Ctr, Div Infect Dis, San Antonio, TX 78229 USA
关键词
D O I
10.1128/AAC.49.4.1664-1665.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1664 / 1665
页数:2
相关论文
共 9 条
[1]  
[Anonymous], [No title captured]
[2]   The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections [J].
Arbeit, RD ;
Maki, D ;
Tally, FP ;
Campanaro, E ;
Eisenstein, BI .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1673-1681
[3]   Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations [J].
Cha, R ;
Rybak, MJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 47 (03) :539-546
[4]   In vitro activity of daptomycin against vancomycin-resistant enterococci of various van types and comparison of susceptibility testing methods [J].
Jorgensen, JH ;
Crawford, SA ;
Kelly, CC ;
Patterson, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3760-3763
[5]  
NCCLS, 2003, M2A8 NCCLS
[6]  
NCCLS, 2003, M7A6 NCCLS
[7]   Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid:: a comparison with quinupristin-dalfopristin [J].
Raad, II ;
Hanna, HA ;
Hachem, RY ;
Dvorak, T ;
Arbuckle, RB ;
Chaiban, G ;
Rice, LB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3583-3585
[8]   Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid [J].
Rahim, S ;
Pillai, SK ;
Gold, HS ;
Venkataraman, L ;
Inglima, K ;
Press, RA .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) :E146-E148
[9]   Linezolid resistance in a clinical isolate of Staphylococcus aureus [J].
Tsiodras, S ;
Gold, HS ;
Sakoulas, G ;
Eliopoulos, GM ;
Wennersten, C ;
Venkataraman, L ;
Moellering, RC ;
Ferraro, MJ .
LANCET, 2001, 358 (9277) :207-208